New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News A Universal Drug Target for Ovarian Cancer Drug Discovery News News | August 2022 Study Shows High Rate of Actionable Mutations in Lung Cancer MedPage Today News | August 2022 Breast Cancer Drug Trial Results in "Unheard-Of" Survival The New York Times News | June 2022 How A Genetic Test Saved This Black Woman’s Life Essence News | April 2022 Genetic Testing: A Life-Saver for Black Women and Breast Cancer WFMZ News | April 2022 UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine Study Precision Oncology News News | April 2022 New Generation of Cancer-Preventing Vaccines Could Wipe Out Tumors Before They Form Science News | April 2022 Genetic Testing Saves Lives. So Why Aren’t More Women Of Color Doing It? Elle Magazine News | October 2021 Older Women with Triple-Negative Breast Cancer Should Undergo Genetic Testing Healio News | October 2021 Cancer Without Chemotherapy: ‘A Totally Different World’ New York Times News | September 2021 Improving Health through Inclusion University of Penn News | September 2021 Black and White Women have the Same Genetic Risk of Breast Cancer, Penn Study Finds. So Why are Black Women More Likely to Develop the Disease? WHYY News | September 2021 My Experience As a BRCA Mutation Carrier Very Well Health News | August 2021 Polygenic Risk Scores for Breast Cancer—Can They Deliver on the Promise of Precision Medicine? JAMA Network News | August 2021 Penn-led Consortium Identifies More Genetic Markers for Inherited Testicular Cancer Penn Medicine News News | July 2021 Black and White Women Have Same Mutations Linked to Breast Cancer Risk Penn Medicine News News | June 2021 34 ASCO Members Receive Fellows Distinction Healio News | June 2021 AstraZeneca Drug Prevents Breast Cancer Caused by BRCA Mutations From Returning Stat News News | June 2021 Pagination First page« First Previous page‹‹ … Page6 Page7 Page8 Page9 Current page10 Page11 Page12 Page13 Page14 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine Study Precision Oncology News News | April 2022
New Generation of Cancer-Preventing Vaccines Could Wipe Out Tumors Before They Form Science News | April 2022
Genetic Testing Saves Lives. So Why Aren’t More Women Of Color Doing It? Elle Magazine News | October 2021
Older Women with Triple-Negative Breast Cancer Should Undergo Genetic Testing Healio News | October 2021
Black and White Women have the Same Genetic Risk of Breast Cancer, Penn Study Finds. So Why are Black Women More Likely to Develop the Disease? WHYY News | September 2021
Polygenic Risk Scores for Breast Cancer—Can They Deliver on the Promise of Precision Medicine? JAMA Network News | August 2021
Penn-led Consortium Identifies More Genetic Markers for Inherited Testicular Cancer Penn Medicine News News | July 2021
Black and White Women Have Same Mutations Linked to Breast Cancer Risk Penn Medicine News News | June 2021
AstraZeneca Drug Prevents Breast Cancer Caused by BRCA Mutations From Returning Stat News News | June 2021